100 related articles for article (PubMed ID: 22288719)
1. Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications.
Hatzimichael E; Dasoula A; Kounnis V; Benetatos L; Lo Nigro C; Lattanzio L; Papoudou-Bai A; Dranitsaris G; Briasoulis E; Crook T
Leuk Lymphoma; 2012 Sep; 53(9):1709-13. PubMed ID: 22288719
[TBL] [Abstract][Full Text] [Related]
2. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme.
Martinez R; Setien F; Voelter C; Casado S; Quesada MP; Schackert G; Esteller M
Carcinogenesis; 2007 Jun; 28(6):1264-8. PubMed ID: 17272309
[TBL] [Abstract][Full Text] [Related]
3. The pro-apoptotic paradox: the BH3-only protein Bcl-2 interacting killer (Bik) is prognostic for unfavorable outcomes in breast cancer.
Pandya V; Glubrecht D; Vos L; Hanson J; Damaraju S; Mackey J; Hugh J; Goping IS
Oncotarget; 2016 May; 7(22):33272-85. PubMed ID: 27120789
[TBL] [Abstract][Full Text] [Related]
4. Methylation-associated dysregulation of the suppressor of cytokine signaling-3 gene in multiple myeloma.
Wilop S; van Gemmeren TB; Lentjes MH; van Engeland M; Herman JG; Brümmendorf TH; Jost E; Galm O
Epigenetics; 2011 Aug; 6(8):1047-52. PubMed ID: 21934357
[TBL] [Abstract][Full Text] [Related]
5. BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma.
Bodet L; Ménoret E; Descamps G; Pellat-Deceunynck C; Bataille R; Le Gouill S; Moreau P; Amiot M; Gomez-Bougie P
Br J Cancer; 2010 Dec; 103(12):1808-14. PubMed ID: 21063407
[TBL] [Abstract][Full Text] [Related]
6. Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.
Draht MX; Smits KM; Jooste V; Tournier B; Vervoort M; Ramaekers C; Chapusot C; Weijenberg MP; van Engeland M; Melotte V
Clin Epigenetics; 2016; 8():44. PubMed ID: 27118999
[TBL] [Abstract][Full Text] [Related]
7. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
8. The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia.
Hatzimichael E; Dasoula A; Shah R; Syed N; Papoudou-Bai A; Coley HM; Dranitsaris G; Bourantas KL; Stebbing J; Crook T
Eur J Haematol; 2010 Jan; 84(1):47-51. PubMed ID: 19737309
[TBL] [Abstract][Full Text] [Related]
9. Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia.
Hatzimichael E; Benetatos L; Dasoula A; Dranitsaris G; Tsiara S; Georgiou I; Syrrou M; Stebbing J; Coley HM; Crook T; Bourantas KL
Leuk Res; 2009 Sep; 33(9):1272-5. PubMed ID: 19423161
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic dysregulation of the death-associated protein kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in multiple myeloma.
Chim CS; Liang R; Fung TK; Choi CL; Kwong YL
J Clin Pathol; 2007 Jun; 60(6):664-9. PubMed ID: 17557868
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of LPP/miR-28 in multiple myeloma.
Li Z; Wong KY; Chan GC; Chim CS
J Clin Pathol; 2018 Mar; 71(3):253-258. PubMed ID: 28775176
[TBL] [Abstract][Full Text] [Related]
12. [Methylation status of IEX-1 gene promotor CpG island in malignant hematopoietic cell lines].
Li XY; Shen JZ; Shen SF; Fu HY; Zhou HR; Wu DS; Zhang YY; Zheng YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):473-6. PubMed ID: 21518511
[TBL] [Abstract][Full Text] [Related]
13. Impact of global and gene-specific DNA methylation pattern in relapsed multiple myeloma patients treated with bortezomib.
Fernández de Larrea C; Martín-Antonio B; Cibeira MT; Navarro A; Tovar N; Díaz T; Rosiñol L; Monzó M; Urbano-Ispizua A; Bladé J
Leuk Res; 2013 Jun; 37(6):641-6. PubMed ID: 23395385
[TBL] [Abstract][Full Text] [Related]
14. Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease.
Hatzimichael E; Dranitsaris G; Dasoula A; Benetatos L; Stebbing J; Crook T; Bourantas KL
Clin Lymphoma Myeloma; 2009 Jun; 9(3):239-42. PubMed ID: 19525194
[TBL] [Abstract][Full Text] [Related]
15. 5-Aza-2'-deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer).
Dai Z; Liu S; Marcucci G; Sadee W
Biochem Biophys Res Commun; 2006 Dec; 351(2):455-61. PubMed ID: 17064661
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of the methylated cytosine-phosphate-guanine sites of protocadherin-10 promoter for evaluating the prognosis of gastric cancer.
Deng J; Liang H; Ying G; Dong Q; Zhang L; Yu J; Fan D; Hao X
J Am Coll Surg; 2014 Nov; 219(5):904-13. PubMed ID: 25260683
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
19. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer.
Tang LP; Cho CH; Hui WM; Huang C; Chu KM; Xia HH; Lam SK; Rashid A; Wong BC; Chan AO
Digestion; 2006; 74(2):85-90. PubMed ID: 17139167
[TBL] [Abstract][Full Text] [Related]
20. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]